SUPERCHARGING THE IMMUNE SYSTEM
Dead / Abandoned — Abandoned — express abandonment (as of 26 Oct 2021)
What this means for you
This application is over — abandoned 25 Oct 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90452908
- Mark type
- Stylized text
- Filed
- 07 Jan 2021
- Abandoned
- 25 Oct 2021
- Attorney of record
- Darin Margules
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic, biologic, cellular, medicinal and immunotherapeutic preparations for the treatment and/or prevention of cancer or tumors, and chronic, infectious, autoimmune, viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, gynecological, oncological, respiratory, neurological, gastrointestinal, hormonal, and dermatological diseases and disorders
- Class 042 — Scientific and technological services: Scientific and technological services and research with diagnostic and/or therapeutic applications in the fields of genetics, vaccines, stem cell therapy, cellular immunotherapy, immunotherapy, gene therapy, cancer therapy, and oncology; medical research with diagnostic and/or therapeutic applications in the fields of genetics, immunotherapy, vaccines, stem cell therapy, cellular immunotherapy, gene therapy, cancer therapy, and oncology; pharmacological research with diagnostic and/or therapeutic applications in the fields of genetics, immunotherapy, vaccines, stem cell therapy, cellular immunotherapy, gene therapy, cancer therapy, and oncology; research and development of medicinal, pharmaceutical, cellular, biologic, medical, diagnostic, therapeutic and immunotherapeutic agents
Owner
- NKORE, LLC, Germantown, TN, US
Prosecution history
- 26 Oct 2021 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 26 Oct 2021 — ABANDONMENT - EXPRESS MAILED
- 25 Oct 2021 — TEAS EXPRESS ABANDONMENT RECEIVED
- 21 Jul 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jul 2021 — NON-FINAL ACTION E-MAILED
- 21 Jul 2021 — NON-FINAL ACTION WRITTEN
- 16 Jul 2021 — ASSIGNED TO EXAMINER
- 06 Apr 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Jan 2021 — NEW APPLICATION ENTERED